Q2 2025 Holdings
Filed 2025-08-28 | 477 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares Russell Top 200 Grow(IWY) | ETP | 464289438 | $247 | 1 | 0.0% |
| First Trust Senior Loan ETF(FTSL) | ETP | 33738D309 | $459 | 10 | 0.0% |
| Hershey Co(HSY) | Common Stock | 427866108 | $1.7K | 10 | 0.0% |
| Q32 BIO Inc(QTTB) | Common Stock | 746964105 | $3.7K | 2,450 | 0.0% |
| Wolfspeed Inc(WOLF*) | Common Stock | 977852102 | $4.0K | 10,000 | 0.0% |
| Onkure Therapeutics Inc(OKUR) | Common Stock | 68277Q105 | $6.2K | 2,576 | 0.0% |
| Pepgen Inc(PEPG) | Common Stock | 713317105 | $7.3K | 6,572 | 0.0% |
| Artiva Biotherapeutics Inc(ARTV) | Common Stock | 04317A107 | $7.4K | 4,893 | 0.0% |
| Mersana Therapeutics Inc | Common Stock | 59045L106 | $7.4K | 25,032 | 0.0% |
| Acrivon Therapeutics Inc(ACRV) | Common Stock | 004890109 | $7.5K | 6,298 | 0.0% |
| IGM Biosciences Inc(1K0) | Common Stock | 449585108 | $7.8K | 6,975 | 0.0% |
| Applied Therapeutics Inc(APLT) | Common Stock | 03828A101 | $8.8K | 28,435 | 0.0% |
| Spdr S&P Dividend ETF(SDY) | ETP | 78464A763 | $10.2K | 75 | 0.0% |
| Sutro Biopharma Inc | Common Stock | 869367102 | $12.1K | 16,964 | 0.0% |
| Quanterix Corp(QTRX) | Common Stock | 74766Q101 | $12.6K | 1,894 | 0.0% |
| GSK PLC(GSK) | ADR | 37733W204 | $13.1K | 338 | 0.0% |
| Charles River Laboratories(CRL) | Common Stock | 159864107 | $13.5K | 89 | 0.0% |
| Biomea Fusion Inc(BMEA) | Common Stock | 09077A106 | $13.6K | 7,546 | 0.0% |
| Pyxis Oncology Inc(PYXS) | Common Stock | 747324101 | $13.7K | 12,442 | 0.0% |
| Illumina Inc(ILMN) | Common Stock | 452327109 | $13.9K | 146 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | Common Stock | 729139105 | $14.3K | 12,329 | 0.0% |
| Repligen Corp(RGEN) | Common Stock | 759916109 | $14.3K | 115 | 0.0% |
| Tscan Therapeutics Inc(TCRX) | Common Stock | 89854M101 | $15.2K | 10,507 | 0.0% |
| Macrogenics Inc(MGNX) | Common Stock | 556099109 | $15.3K | 12,671 | 0.0% |
| Climb BIO Inc(CLYM) | Common Stock | 28658R106 | $16.8K | 13,572 | 0.0% |
| Edwards Lifesciences Corp(EW) | Common Stock | 28176E108 | $20.0K | 256 | 0.0% |
| C4 Therapeutics Inc(CCCC) | Common Stock | 12529R107 | $20.4K | 14,261 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | Common Stock | 46333X108 | $23.3K | 32,501 | 0.0% |
| Nkarta Inc(NKTX) | Common Stock | 65487U108 | $23.7K | 14,252 | 0.0% |
| Neumora Therapeutics Inc(NMRA) | Common Stock | 640979100 | $23.8K | 32,486 | 0.0% |
| Align Technology Inc(ALGN) | Common Stock | 016255101 | $25.2K | 133 | 0.0% |
| Fate Therapeutics Inc(FATE) | Common Stock | 31189P102 | $25.8K | 23,024 | 0.0% |
| Lyell Immunopharma Inc(LYEL) | Common Stock | 55083R203 | $26.2K | 2,966 | 0.0% |
| Vanguard Info Tech ETF(VGT) | ETP | 92204A702 | $26.5K | 40 | 0.0% |
| Kyverna Therapeutics Inc(KYTX) | Common Stock | 501976104 | $26.6K | 8,680 | 0.0% |
| Lexeo Therapeutics Inc(LXEO) | Common Stock | 52886X107 | $26.8K | 6,667 | 0.0% |
| Alector Inc(ALEC) | Common Stock | 014442107 | $28.1K | 20,083 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | Common Stock | 29251M106 | $32.5K | 4,293 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | Common Stock | 35104E100 | $34.5K | 9,304 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | Common Stock | 92915B106 | $34.6K | 11,114 | 0.0% |
| Omeros Corp(OMER) | Common Stock | 682143102 | $35.3K | 11,768 | 0.0% |
| Editas Medicine Inc(EDIT) | Common Stock | 28106W103 | $37.0K | 16,813 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | Common Stock | 517125100 | $37.2K | 12,860 | 0.0% |
| Cargo Therapeutics Inc(CRGX) | Common Stock | 14179K101 | $38.2K | 9,262 | 0.0% |
| Design Therapeutics Inc(DSGN) | Common Stock | 25056L103 | $38.4K | 11,402 | 0.0% |
| Esperion Therapeutics Inc(ESPR) | Common Stock | 29664W105 | $39.2K | 39,808 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | Common Stock | 810648105 | $40.4K | 10,603 | 0.0% |
| Codexis Inc(CDXS) | Common Stock | 192005106 | $40.6K | 16,639 | 0.0% |
| AC Immune SA(ACIU) | Common Stock | H00263105 | $40.9K | 20,167 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | Common Stock | 984241109 | $41.0K | 9,097 | 0.0% |